InvestorsHub Logo
Followers 91
Posts 62901
Boards Moderated 2
Alias Born 04/01/2001

Re: garhart post# 3

Sunday, 03/07/2004 3:24:13 PM

Sunday, March 07, 2004 3:24:13 PM

Post# of 90
One problem with that statement, it's not "Mark's" Elan. It's Kelly Martin's Elan. It's Mark's stock pick from 5.41 up. And it has been one of the most successful picks I've seen anyone select in the past three months.

My next watch. . .RSTO (Restorative Hardware). January sales were up 23% over the previous year and Internet sales were up 80+% for the same month. The company is coming out of the "market bubble burst" slump. More and more people are looking for "redecorating" as they have boomed into new homes. Over 100 stores in 31 states. Present stock price is a little over 5 bucks.

http://139.142.147.218/StockChart_ImageOnly.dll?cus=0&co=ask&i_chart=0&inm=5&ind=2&a....

VLTS: George Soros upped his anty in this one. Worth watching.
The stock may or may not hold ground. But when billionaires are buying. . .I'm watching.

From Business Week:

What George Soros Sees In Valentis
by Gene G. Marcial / Mar 08 '04


You might call biotech Valentis (VLTS) a late bloomer. On Dec. 29, it traded at 2.49 but by Feb. 25 had jumped to 5.72. What happened? George Soros, through his Perseus-Soros BioPharmaceutical Fund, bought more shares in a private deal, upping his stake to 20%. Valentis' lead product, Deltavasc, is a novel angiogenesis -- that is, it's designed to grow new blood vessels in patients suffering from arterial disease. Dennis Purcell, managing director at Perseus-Soros Fund, says Soros wants to help biotechs with good products complete their clinical trials. Initial results from Valentis' Phase 2 trials, which test for safety, look promising, ......


:o)


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.